The global rat and mouse model market, valued at $1.46 billion in 2023, is expected to reach $3.10 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.10% from 2024 to 2034. This growth is driven by increasing research and development activities in pharmaceutical and healthcare sectors.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5212
Rat and mouse models are essential for preclinical research, offering insights into various biological processes and disease mechanisms. While mice have historically been the preferred model, rats are gaining popularity in specialized fields like neurology due to their unique advantages. Advances in gene-editing tools have expanded the capabilities of creating disease models in these species, driving further market growth.
Artificial intelligence (AI) and machine learning (ML) are transforming preclinical studies involving rat and mouse models by:
Integrating AI with animal model data and clinical human data enhances the relevance of findings, bridging the gap between preclinical and clinical research. For instance, in June 2024, researchers created a virtual rat with an AI brain to simulate real rats’ movements, yielding new insights into brain function that could revolutionize neurology and robotics.
Key players in this market include:
The rat and mouse model market is poised for continued growth due to ongoing research across diverse sectors like healthcare, pharmaceuticals, biotechnology, and cosmetics. Animal studies play a critical role in understanding disease mechanisms and developing new treatments, despite ethical concerns surrounding their use.
In 2022, 2.76 million scientific operations involving live animals were conducted in the UK, with 1.51 million for experimental purposes and 1.25 million (45% of all procedures) for creating and breeding genetically altered (GA) animals.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/rat-and-mouse-model-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5212
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The rheumatoid arthritis drugs market size achieved a value of USD 17.87 billion in 2023 with this trajectory, it is… Read More
The ambulatory surgical centers market accounted for USD 94.57 billion in 2022 and is predicted to increase to USD 167.1… Read More
The global dental services market accounted for USD 432.1 billion in 2022 and is expected to hit US$ 699.7 billion… Read More
The cell and gene therapy manufacturing market size is estimated for US$ 3,755.4 million in 2022 to reach an estimate… Read More
The global CAR T-Cell therapy market is estimated to grow from USD 3.87 billion in 2022 at 29.8% CAGR (2023-2032)… Read More
Overview The automotive electronic stability control system market was valued at USD 40.65 billion in 2022 and is expected to… Read More